Purpose:
The Associate Director works independently with guidance from a Director and is responsible for developing and implementing HEOR strategy and tactics for multiple indications within a product, or across products within the same indication, spanning US and global responsibilities. The role requires technical expertise in health economics and outcomes research (HEOR), leveraging innovative evidence generation to optimize treatment decisions, support label expansion/enhancement, and maximize registration, while fostering a culture of learning and personal development.
Key Responsibilities:
- Lead HEOR as a subject matter expert on cross-functional teams (Pipeline Commercialization Model, brand planning) ensuring alignment and integration of global HEOR strategies into broader evidence plans.
- Asset leadership for specialty products including brand team workshop participation, IBT/IEST/VAT meeting attendance, and proactive HEOR/Market Access/MPS engagement.
- Direct execution of research projects: from conceptualization, protocol/statistical analysis plan development, vendor management, results communication, publication, to pull-through materials.
- Partner with field teams and affiliates to train/educate on HEOR materials and support local value communication needs.
- Collaborate with Centers of Excellence (PCOR, RWE) to ensure robust and innovative research delivery.
- Utilize HEOR expertise and payer/HTA insights to shape clinical trial measurement strategies and interface with global regulatory bodies to support label negotiations.
- Partner with global stakeholders and country affiliates for HTA submissions and evidence generation.
- Build relationships with external experts (clinical, payer, patient advocacy) for protocol design, results interpretation, and publications.
- Manage and allocate asset-specific budgets, ensuring projects are delivered within scope and timelines.
- Ensure compliance of HEOR studies with research standards and policies.
- Partner effectively with internal stakeholders (HEOR Therapeutic Area teams, Market Access, Medical Affairs, Global teams) for evidence dissemination to payers, providers, patients, and policymakers.
